6-methyl-2-ethyl-3-hydroxypyridine has been researched along with Atherosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anatskaia, LN; Matusevich, LI; Nechipurenko, NI; Pashkovskaia, ID; Shcherbina, NIu | 1 |
| Dolgushina, AI | 1 |
2 trial(s) available for 6-methyl-2-ethyl-3-hydroxypyridine and Atherosclerosis
| Article | Year |
|---|---|
[Effect of intravenous laser irradiation on some blood biochemical indicators in the acute stage of lacunar infarcts].
Topics: Aged; Antioxidants; Atherosclerosis; Blood; C-Reactive Protein; Catalase; Female; Humans; Lipid Metabolism; Lipid Peroxidation; Lipoproteins, LDL; Low-Level Light Therapy; Male; Middle Aged; Picolines; Stroke, Lacunar; Superoxide Dismutase | 2014 |
[Efficacy of emoxipine and mexidol in patients with chronic disorders of the digestive system and atherosclerosis of the abdominal aorta].
Topics: Abdominal Pain; Aged; Antioxidants; Aorta, Abdominal; Atherosclerosis; Chronic Disease; Digestive System Diseases; Female; Humans; Infusions, Intravenous; Lipid Peroxidation; Lipid Peroxides; Male; Picolines; Single-Blind Method; Treatment Outcome | 2011 |